Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00000157Phase 3Terminated
Phase 3, randomised, double-blind trial of aspirin in cataract (4 arms), sponsored by National Eye Institute. Primary endpoints: Incidence of cataract at 5 years and Time to cataract diagnosis at 5 years. Started Apr 1982; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00000157.